Chemical Engineering
Pharmaceutical Sciences
Xiuling Lu
Professor/Pharmaceutical Science

Are you Xiuling Lu?

How to update your information.
Grants

12 Grants

Investigating the Impact of API Purity, Lipid Source and Manufacturing Process on Performance and Quality of Complex siRNA Lipid Nanoparticles
Sponsor: DHHS/FDA/Food and Drug Administration
Authors: Xiuling Lu
Funding: $1,530,889
2023-09-22 - 2027-09-21
In Vitro and In Vivo Assessment of Ophthalmic Ointments for Generic Product Equivalence
Sponsor: DHHS/FDA/Food and Drug Administration
Authors: Xiuling Lu
Funding: $1,141,038
2018-09-11 - 2022-12-10
Assessing Long-Acting Injectable Formulations Using in Vivo Imaging
Sponsor: DHHS/FDA/Food and Drug Administration
Authors: Xiuling Lu
Funding: $1,131,742
2020-09-30 - 2024-09-29
Cryopreservation of T cells with exploration of cell freeze drying
Sponsor: Janssen Pharmaceuticals
Authors: Xiuling Lu
Funding: $409,797
2020-11-20 - 2023-11-20
Nanoparticle-based Intraperitoneal Delivery of Combined Chemo-brachytherapy for Treatment of Ovarian Cancer
Sponsor: DHHS/NIH/National Cancer Institute/NAMI Therapeutics
Authors: Xiuling Lu
Funding: $357,855
2022-08-19 - 2025-07-31
CPPR: Impact of Lyoprotectants and Residual Moisture on Product Stability of Freeze-Dried mRNA-Lipid Nanoparticles
Sponsor: Mixed Sources
Authors: Xiuling Lu
Funding: $160,000
2023-01-01 - 2025-12-31
CPPR: Impact of Controlled Ice Nucleation and Cell Dehydration on T-cell Cryopreservation
Sponsor: Mixed Sources
Authors: Xiuling Lu
Funding: $156,000
2024-01-01 - 2025-12-31
Evaluating the Impact of Preservative and Surfactant Content variations in Otic Formulations
Sponsor: DHHS/FDA/Food and Drug Administration/Stanford University
Authors: Xiuling Lu
Funding: $0
2024-09-01 - 2026-08-31
A New Platform for Nanostructured Diagnostic Material Application to Facilitate the Discovery of Early Diagnostic Biomarkers for Neurodegenerative Diseases
Sponsor: DHHS/NIH/National Institutes of Health/CrystalNeuro
Authors: Xiuling Lu
Funding: $0
2024-12-02 - 2026-12-01
Tumor-specific internal radiation therapy and immunomodulation for treating metastatic peritoneal cancers
Sponsor: DHHS/NIH/National Cancer Institute
Authors: Xiuling Lu
Funding: $0
2025-07-01 - 2030-06-30
Elastic Liposomal Nanoparticles for Middle Ear Drug Delivery
Sponsor: DHHS/NIH/National Institutes of Health/Stanford University
Authors: Xiuling Lu
Funding: $0
2024-07-01 - 2029-06-30
NIPTE Consortium for Enhancing Drug Development and Regulatory Science
Sponsor: DHHS/FDA/Food and Drug Administration/National Institute of Pharmaceutical Technology and Education
Authors: Xiuling Lu
Funding: $0
2024-09-01 - 2029-08-31